2023
DOI: 10.1016/j.jmacro.2023.103519
|View full text |Cite
|
Sign up to set email alerts
|

Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…where Inp i,L2 , Env i,L2 , and Eco i,L2 denote the indicators of the innovation input, innovation environment, and economic environment two periods prior to a patent application by the ith cohort in their associated regions. Studies have shown that there are time lags between a firm's R&D investment and its innovation output [53][54][55]. However, the actual time lags remain debatable (see [56]).…”
Section: Extended Model: Regional Innovation Value Modelmentioning
confidence: 99%
“…where Inp i,L2 , Env i,L2 , and Eco i,L2 denote the indicators of the innovation input, innovation environment, and economic environment two periods prior to a patent application by the ith cohort in their associated regions. Studies have shown that there are time lags between a firm's R&D investment and its innovation output [53][54][55]. However, the actual time lags remain debatable (see [56]).…”
Section: Extended Model: Regional Innovation Value Modelmentioning
confidence: 99%